Joris Hemelaar

4.0k total citations · 1 hit paper
44 papers, 2.5k citations indexed

About

Joris Hemelaar is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Joris Hemelaar has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 12 papers in Virology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Joris Hemelaar's work include HIV/AIDS Research and Interventions (28 papers), HIV Research and Treatment (12 papers) and Global Maternal and Child Health (11 papers). Joris Hemelaar is often cited by papers focused on HIV/AIDS Research and Interventions (28 papers), HIV Research and Treatment (12 papers) and Global Maternal and Child Health (11 papers). Joris Hemelaar collaborates with scholars based in United Kingdom, South Africa and United States. Joris Hemelaar's co-authors include Eleanor Gouws, Saladin Osmanov, Peter D. Ghys, Benedikt M. Kessler, Hidde L. Ploegh, Shona Kirtley, Victor S. Lelyveld, Stephen Kennedy, Ruth Corrigan and Sally Hopewell and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Joris Hemelaar

42 papers receiving 2.5k citations

Hit Papers

Global trends in molecular epidemiology of HIV-1 during 2... 2011 2026 2016 2021 2011 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global trends in molecular epidemiology of HIV-1 during 2000–2007
    2011 530 citations Joris Hemelaar, Eleanor Gouws et al. AIDS profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joris Hemelaar United Kingdom 19 1.4k 1.3k 665 575 323 44 2.5k
Chris Verhofstede Belgium 31 1.8k 1.3× 1.9k 1.4× 600 0.9× 260 0.5× 285 0.9× 101 2.7k
Boris Renjifo United States 29 1.5k 1.1× 1.5k 1.2× 566 0.9× 287 0.5× 462 1.4× 48 2.6k
James McMahon Australia 28 1.3k 0.9× 917 0.7× 612 0.9× 482 0.8× 345 1.1× 91 2.4k
Nuria Izquierdo‐Useros Spain 30 822 0.6× 735 0.6× 281 0.4× 761 1.3× 879 2.7× 76 2.6k
Maureen M. Goodenow United States 35 1.8k 1.3× 2.4k 1.8× 709 1.1× 842 1.5× 991 3.1× 118 4.0k
Stéphane Priet France 20 641 0.5× 740 0.6× 362 0.5× 667 1.2× 434 1.3× 39 1.8k
Margaret E. Feeney United States 26 643 0.5× 1.3k 1.0× 364 0.5× 326 0.6× 1.5k 4.7× 62 2.5k
Mark de Souza United States 29 1.4k 1.0× 1.7k 1.3× 653 1.0× 478 0.8× 596 1.8× 99 2.9k
A. Benedetto Italy 27 509 0.4× 524 0.4× 721 1.1× 630 1.1× 381 1.2× 94 2.1k
Eleftherios Michailidis United States 24 1.2k 0.8× 531 0.4× 726 1.1× 691 1.2× 252 0.8× 46 2.1k

Countries citing papers authored by Joris Hemelaar

Since Specialization
Citations

This map shows the geographic impact of Joris Hemelaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joris Hemelaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joris Hemelaar more than expected).

Fields of papers citing papers by Joris Hemelaar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joris Hemelaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joris Hemelaar. The network helps show where Joris Hemelaar may publish in the future.

Co-authorship network of co-authors of Joris Hemelaar

This figure shows the co-authorship network connecting the top 25 collaborators of Joris Hemelaar. A scholar is included among the top collaborators of Joris Hemelaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joris Hemelaar. Joris Hemelaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Kirtley, Shona, et al.. (2024). Perinatal outcomes associated with pre-exposure prophylaxis for HIV prevention during pregnancy: a systematic review and meta-analysis. EClinicalMedicine. 70. 102532–102532. 5 indexed citations
5.
Yu, Qiuyan, et al.. (2024). Predicting risk of preterm birth in singleton pregnancies using machine learning algorithms. Frontiers in Big Data. 7. 1291196–1291196. 3 indexed citations
6.
Elangovan, Ramyiadarsini, et al.. (2023). Global associations of key populations with HIV-1 recombinants: a systematic review, global survey, and individual participant data meta-analysis. Frontiers in Public Health. 11. 1153638–1153638. 5 indexed citations
7.
Kumarendran, Mary, et al.. (2023). Adverse perinatal outcomes associated with antiretroviral therapy in women living with HIV: A systematic review and meta-analysis. Frontiers in Medicine. 9. 924593–924593. 6 indexed citations
8.
9.
Elangovan, Ramyiadarsini, et al.. (2021). Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study. Frontiers in Microbiology. 12. 690647–690647. 18 indexed citations
10.
Chan, Christina Y., et al.. (2020). γδ T cell frequencies are altered in HIV positive pregnant South African women and are associated with preterm birth. PLoS ONE. 15(6). e0235162–e0235162. 6 indexed citations
11.
Staines-Urias, Eleonora, et al.. (2019). Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa. AIDS. 33(10). 1623–1633. 42 indexed citations
12.
Kirtley, Shona, et al.. (2015). Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. The Lancet HIV. 3(1). e33–e48. 180 indexed citations
13.
Hemelaar, Joris, et al.. (2012). Breech presentation of singletons at term delivery: 10 years of ECV clinic experience. Oxford University Research Archive (ORA) (University of Oxford). 119. 11–12. 2 indexed citations
14.
Aldrich, Cassandra & Joris Hemelaar. (2012). Global HIV-1 diversity surveillance. Trends in Molecular Medicine. 18(12). 691–694. 25 indexed citations
15.
Hemelaar, Joris. (2012). Implications of HIV diversity for the HIV-1 pandemic. Journal of Infection. 66(5). 391–400. 109 indexed citations
16.
Hemelaar, Joris. (2007). Minimising risk in first-in-man trials. The Lancet. 369(9572). 1496–1497. 3 indexed citations
17.
Hamill, Matthew M., et al.. (2007). Time to move towards opt-out testing for HIV in the UK. BMJ. 334(7608). 1352–1354. 32 indexed citations
18.
Hemelaar, Joris, Eleanor Gouws, Peter D. Ghys, & Saladin Osmanov. (2006). Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 20(16). W13–W23. 450 indexed citations
19.
Laugel, Bruno, Jonathan M. Boulter, Nikolai M. Lissin, et al.. (2004). Design of Soluble Recombinant T Cell Receptors for Antigen Targeting and T Cell Inhibition. Journal of Biological Chemistry. 280(3). 1882–1892. 64 indexed citations
20.
Hemelaar, Joris, Anna Borodovsky, Benedikt M. Kessler, et al.. (2003). Specific and Covalent Targeting of Conjugating and Deconjugating Enzymes of Ubiquitin-Like Proteins. Molecular and Cellular Biology. 24(1). 84–95. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Verhofstede Breakdown of academic impact, for papers by Boris Renjifo Breakdown of academic impact, for papers by James McMahon Breakdown of academic impact, for papers by Nuria Izquierdo‐Useros Breakdown of academic impact, for papers by Maureen M. Goodenow Breakdown of academic impact, for papers by Stéphane Priet Breakdown of academic impact, for papers by Margaret E. Feeney Breakdown of academic impact, for papers by Mark de Souza Breakdown of academic impact, for papers by A. Benedetto Breakdown of academic impact, for papers by Eleftherios Michailidis
Rankless by CCL
2026